van Oers MH - Search Results

1

[Systematic diagnosis of erythrocytosis].

de Heer K, Silbermann MH, Koene HR, Biemond BJ, Muller HP, van Oers MH. de Heer K, et al. Among authors: van oers mh. Ned Tijdschr Geneeskd. 2007 Aug 11;151(32):1770-6. Ned Tijdschr Geneeskd. 2007. PMID: 17822247 Review. Dutch.

2

Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis.

de Heer K, Kok MG, Fens N, Weersink EJ, Zwinderman AH, van der Schee MP, Visser CE, van Oers MH, Sterk PJ. de Heer K, et al. Among authors: van der schee mp, van oers mh. J Clin Microbiol. 2016 Mar;54(3):569-75. doi: 10.1128/JCM.02214-15. Epub 2015 Dec 16. J Clin Microbiol. 2016. PMID: 26677251 Free PMC article.

3

Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA).

Klein SK, Biemond BJ, van Oers MH. Klein SK, et al. Among authors: van oers mh. Ann Hematol. 2007 Dec;86(12):917-8. doi: 10.1007/s00277-007-0333-3. Epub 2007 Jul 10. Ann Hematol. 2007. PMID: 17619879 Free PMC article. Review. No abstract available.

4

eNose technology can detect and classify human pathogenic molds in vitro: a proof-of-concept study of Aspergillus fumigatus and Rhizopus oryzae.

de Heer K, Vonk SI, Kok M, Kolader M, Zwinderman AH, van Oers MH, Sterk PJ, Visser CE. de Heer K, et al. Among authors: van oers mh. J Breath Res. 2016 Jul 22;10(3):036008. doi: 10.1088/1752-7155/10/3/036008. J Breath Res. 2016. PMID: 27447026

5

Correction for de Heer et al., Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis.

de Heer K, Kok MGM, Fens N, Weersink EJM, Zwinderman AH, van der Schee MPC, Visser CE, van Oers MHJ, Sterk PJ. de Heer K, et al. J Clin Microbiol. 2016 Jul;54(7):1926. doi: 10.1128/JCM.00748-16. J Clin Microbiol. 2016. PMID: 27343292 Free PMC article. No abstract available.

6

Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography-mass spectrometry.

Gerritsen MG, Brinkman P, Escobar N, Bos LD, de Heer K, Meijer M, Janssen HG, de Cock H, Wösten HAB, Visser CE, van Oers MHJ, Sterk PJ. Gerritsen MG, et al. Among authors: van oers mhj. Med Mycol. 2018 Feb 1;56(2):253-256. doi: 10.1093/mmy/myx035. Med Mycol. 2018. PMID: 28525576 Clinical Trial.

7

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.

Cornelissen JJ, van der Holt B, Verhoef GE, van't Veer MB, van Oers MH, Schouten HC, Ossenkoppele G, Sonneveld P, Maertens J, van Marwijk Kooy M, Schaafsma MR, Wijermans PW, Biesma DH, Wittebol S, Voogt PJ, Baars JW, Zachée P, Verdonck LF, Löwenberg B, Dekker AW; Dutch-Belgian HOVON Cooperative Group. Cornelissen JJ, et al. Among authors: van marwijk kooy m, van oers mh, van t veer mb, van der holt b. Blood. 2009 Feb 5;113(6):1375-82. doi: 10.1182/blood-2008-07-168625. Epub 2008 Nov 6. Blood. 2009. PMID: 18988865 Free article.

8

A case of ATRA-induced isolated myocarditis in the absence of circulating malignant cells: demonstration of the t(15;17) translocation in the inflammatory infiltrate by in situ hybridisation.

van Rijssel RH, Wegman J, Oud ME, Pals ST, van Oers MH. van Rijssel RH, et al. Among authors: van oers mh. Leuk Res. 2010 Jul;34(7):e142-4. doi: 10.1016/j.leukres.2009.12.005. Epub 2010 Jan 8. Leuk Res. 2010. PMID: 20060166 No abstract available.

9

Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.

Lokhorst HM, van der Holt B, Cornelissen JJ, Kersten MJ, van Oers M, Raymakers R, Minnema MC, Zweegman S, Janssen JJ, Zijlmans M, Bos G, Schaap N, Wittebol S, de Weerdt O, Ammerlaan R, Sonneveld P. Lokhorst HM, et al. Blood. 2012 Jun 28;119(26):6219-25; quiz 6399. doi: 10.1182/blood-2011-11-393801. Epub 2012 Mar 22. Blood. 2012. PMID: 22442350 Free article. Clinical Trial.

10

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.

Segeren CM, Sonneveld P, van der Holt B, Vellenga E, Croockewit AJ, Verhoef GE, Cornelissen JJ, Schaafsma MR, van Oers MH, Wijermans PW, Fibbe WE, Wittebol S, Schouten HC, van Marwijk Kooy M, Biesma DH, Baars JW, Slater R, Steijaert MM, Buijt I, Lokhorst HM; Dutch-Belgian Hemato-Oncology Cooperative Study Group. Segeren CM, et al. Among authors: van marwijk kooy m, van oers mh, van der holt b. Blood. 2003 Mar 15;101(6):2144-51. doi: 10.1182/blood-2002-03-0889. Epub 2002 Nov 27. Blood. 2003. PMID: 12456509 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page